microRNA information: hsa-miR-382-5p

SectionIDlink
Mature name: hsa-miR-382-5pmiRbase
Accession: MIMAT0000737miRbase
Precursor name: hsa-mir-382 miRbase
Precursor accession: MI0000790miRbase
Symbol: MIR382HGNC
RefSeq ID: NR_029874GenBank
Sequence: GAAGUUGUUCGUGGUGGAUUCG


Reported expression in cancers: hsa-miR-382-5p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-382-5p

breast cancerderegulation"We identified seven miRNAs that were differentiall ......"27409424
hsa-miR-382-5p

colorectal cancerdownregulation"MiR-382 has been found to have a decreased express ......"26800338


Reported cancer pathway affected by hsa-miR-382-5p

miRNAcancerpathwayreportingPUBMEDfunctional study
hsa-miR-382-5p

sarcomaEpithelial mesenchymal transition pathway"miR 382 inhibits osteosarcoma metastasis and relap ......"25292190


Reported cancer prognosis affected by hsa-miR-382-5p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-382-5p

breast cancerrecurrence"We identified seven miRNAs that were differentiall ......"27409424
hsa-miR-382-5p

breast cancerprogression; metastasis; tumorigenesis; poor survival; worse prognosis"MicroRNA 382 5p aggravates breast cancer progressi ......"27705918
hsa-miR-382-5p

colorectal cancertumorigenesis"MiR 382 inhibits cell growth and invasion by targe ......"26800338Luciferase
hsa-miR-382-5p

esophageal cancerpoor survival; staging; worse prognosis"Downregulation of microRNA 382 is associated with ......"26078564
hsa-miR-382-5p

melanomametastasis; progression"We identified two microRNAs hsa-miR-382 hsa-miR-51 ......"25677173
hsa-miR-382-5p

prostate cancermetastasis"MicroRNA 382 inhibits prostate cancer cell prolife ......"27748848Western blot; Luciferase
hsa-miR-382-5p

sarcomametastasis; poor survival"miR 382 inhibits osteosarcoma metastasis and relap ......"25292190
hsa-miR-382-5p

sarcomadrug resistance; poor survival; progression"miR 382 inhibits tumor growth and enhance chemosen ......"25344865


Reported gene related to hsa-miR-382-5p

miRNAcancergenereportingPUBMED
hsa-miR-382-5p

melanomaCTTN"Depletion of CTTN partially recapitulates miR-382 ......"25677173
hsa-miR-382-5p

sarcomaHIPK3"Overexpression of miR-382 inhibited cell growth an ......"25344865
hsa-miR-382-5p

sarcomaKLF12"Overexpression of miR-382 inhibited cell growth an ......"25344865
hsa-miR-382-5p

colorectal cancerNR2F2"MiR 382 inhibits cell growth and invasion by targe ......"26800338
hsa-miR-382-5p

breast cancerRERG"Furthermore we found that miR-382-5p directly targ ......"27705918
hsa-miR-382-5p

ovarian cancerROR1"miR 382 inhibits migration and invasion by targeti ......"26575700
hsa-miR-382-5p

prostate cancerSNAI1"Moreover the restoration of COUP‑TFII expression ......"27748848
hsa-miR-382-5p

sarcomaYBX1"Furthermore we demonstrated that miR-382 exerted i ......"25292190


Expression profile in cancer corhorts:



Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-382-5p
LYPLAL1
10 cancers: BLCA; BRCA; KIRC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; STAD
MirTarget
TCGA BLCA -0.104; TCGA BRCA -0.103; TCGA KIRC -0.085; TCGA LGG -0.079; TCGA LIHC -0.053; TCGA LUAD -0.076; TCGA LUSC -0.121; TCGA PRAD -0.117; TCGA SARC -0.095; TCGA STAD -0.137
hsa-miR-382-5p
KLHL24
9 cancers: BLCA; COAD; KIRC; KIRP; LGG; LUAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.127; TCGA COAD -0.179; TCGA KIRC -0.055; TCGA KIRP -0.079; TCGA LGG -0.076; TCGA LUAD -0.067; TCGA SARC -0.053; TCGA STAD -0.094; TCGA UCEC -0.054
hsa-miR-382-5p
LUC7L3
9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC
mirMAP
TCGA BLCA -0.126; TCGA BRCA -0.076; TCGA ESCA -0.122; TCGA HNSC -0.082; TCGA KIRC -0.104; TCGA KIRP -0.162; TCGA LGG -0.104; TCGA LUAD -0.076; TCGA LUSC -0.1
hsa-miR-382-5p
HEMK1
9 cancers: BLCA; BRCA; ESCA; KIRP; LUAD; LUSC; PAAD; SARC; STAD
mirMAP
TCGA BLCA -0.09; TCGA BRCA -0.082; TCGA ESCA -0.161; TCGA KIRP -0.144; TCGA LUAD -0.076; TCGA LUSC -0.1; TCGA PAAD -0.124; TCGA SARC -0.052; TCGA STAD -0.111
hsa-miR-382-5p
LIMD1
10 cancers: BLCA; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD
mirMAP
TCGA BLCA -0.141; TCGA ESCA -0.18; TCGA KIRP -0.072; TCGA LGG -0.127; TCGA LIHC -0.068; TCGA LUAD -0.153; TCGA LUSC -0.196; TCGA PAAD -0.136; TCGA PRAD -0.084; TCGA STAD -0.093
hsa-miR-382-5p
ZNF19
10 cancers: BLCA; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; OV; PRAD; STAD
mirMAP
TCGA BLCA -0.079; TCGA ESCA -0.145; TCGA KIRC -0.089; TCGA KIRP -0.172; TCGA LGG -0.106; TCGA LUAD -0.074; TCGA LUSC -0.076; TCGA OV -0.078; TCGA PRAD -0.067; TCGA STAD -0.1
hsa-miR-382-5p
TAPT1
13 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD
mirMAP
TCGA BLCA -0.097; TCGA BRCA -0.09; TCGA COAD -0.134; TCGA ESCA -0.191; TCGA KIRC -0.079; TCGA LGG -0.06; TCGA LIHC -0.089; TCGA LUAD -0.11; TCGA LUSC -0.128; TCGA OV -0.058; TCGA PRAD -0.051; TCGA SARC -0.07; TCGA STAD -0.19
hsa-miR-382-5p
MYO6
10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; UCEC
mirMAP
TCGA BLCA -0.122; TCGA BRCA -0.06; TCGA ESCA -0.24; TCGA HNSC -0.161; TCGA KIRC -0.09; TCGA KIRP -0.093; TCGA LUAD -0.081; TCGA LUSC -0.139; TCGA PRAD -0.137; TCGA UCEC -0.138
hsa-miR-382-5p
CD2AP
9 cancers: BLCA; COAD; ESCA; KIRC; LUAD; LUSC; PAAD; PRAD; UCEC
mirMAP
TCGA BLCA -0.111; TCGA COAD -0.149; TCGA ESCA -0.28; TCGA KIRC -0.065; TCGA LUAD -0.052; TCGA LUSC -0.086; TCGA PAAD -0.132; TCGA PRAD -0.143; TCGA UCEC -0.107
hsa-miR-382-5p
RAB3IP
9 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; PRAD
mirMAP
TCGA BRCA -0.092; TCGA CESC -0.088; TCGA COAD -0.076; TCGA HNSC -0.099; TCGA KIRC -0.178; TCGA KIRP -0.196; TCGA LGG -0.084; TCGA LUAD -0.106; TCGA PRAD -0.068
hsa-miR-382-5p
XK
9 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; PRAD; SARC; STAD
miRNATAP
TCGA BRCA -0.133; TCGA CESC -0.192; TCGA COAD -0.225; TCGA ESCA -0.566; TCGA HNSC -0.166; TCGA LUAD -0.124; TCGA PRAD -0.237; TCGA SARC -0.438; TCGA STAD -0.443




Enriched cancer pathways of putative targets